021-51111890
购物车（）
sales@molnova.cn
Glycogen phosphorylase-IN-1
CAS No. 648926-15-2
Glycogen phosphorylase-IN-1 ( —— )
产品货号. M34962 CAS No. 648926-15-2
Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥4674 | 有现货 |
|
| 10MG | ￥6536 | 有现货 |
|
| 25MG | ￥9179 | 有现货 |
|
| 50MG | ￥12741 | 有现货 |
|
| 100MG | ￥16650 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Glycogen phosphorylase-IN-1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
-
产品描述Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Phosphorylase
-
研究领域——
-
适应症——
化学信息
-
CAS Number648926-15-2
-
分子量412.78
-
分子式C17H15ClF2N4O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(NC(=O)C1=CC(F)=C(F)C=C1Cl)NC2=CC(=CC=C2OC)NC(=O)NC
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
4-Fluoro-D-phenylala...
4-氟-D-苯丙氨酸盐酸盐是一种氨基酸盐。
-
Astragaloside(b)
黄芪甲苷可以通过减弱雄性大鼠小胶质细胞的激活来防止 TBI 后的脑挫裂伤和神经元凋亡。黄芪甲苷诱导NB4细胞凋亡可能与BCL-2和NF-κB表达下调，最终激活caspase-3相对活性有关。
-
Lasiocarpine
Lasiocarpine is a pyrrolizidine alkaloid, it has acute cytotoxicity in human and hepatic cell lines.
